Natco Pharma Share Price
04 Sep, 2026 3:58 PM (IST)
Natco Pharma Performance
- Today's Low
- ₹827
- Today's High
- ₹842
- 52 Week Low
- ₹789
- 52 Week High
- ₹1,227
- Open Price₹839
- Previous Close₹838
- Volume470,958
- 50 DMA₹906.40
- 100 DMA₹933.20
- 200 DMA₹943.80
Natco Pharma Chart
Investment Returns
- Over 1 Month -9.63%
- Over 3 Month -9.8%
- Over 6 Month -13.06%
- Over 1 Year -3.14%
Smart Investing Starts Here Start SIP with Natco Pharma for Steady Growth!
Natco Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 13
- PEG Ratio
- -0.4
- Market Cap Cr
- 14,842
- P/B Ratio
- 1.6
- Average True Range
- 22.7
- EPS
- 63.9
- Dividend Yield
- 0.5
- MACD Signal
- -23.4
- RSI
- 29.17
- MFI
- 13.74
Latest Stock News Updates
News Paper Publication
- BSE India
- 11 hours 28 minutes ago
Notice of 43rd Annual General Meeting of the Company scheduled to be held on Wednesday, the September 30, 2026 at 11:00 AM (IST)
- BSE India
- 1 day 4 hours ago
Business Responsibility and Sustainability Report
- BSE India
- 1 day 4 hours ago
Natco Pharma Financials
Natco Pharma Technicals
EMA & SMA
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹871.10
- 50 Day
- ₹906.40
- 100 Day
- ₹933.20
- 200 Day
- ₹943.80
Resistance and Support
- R3 853.40
- R2 847.60
- R1 838.10
- S1 822.80
- S2 817.00
- S3 807.50
Natco Pharma Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-08-14 | Quarterly Results & Interim Dividend | |
| 2026-05-29 | Audited Results | |
| 2026-03-24 | Scheme of Arrangement | Inter alia, to consider among other things, the Scheme of Arrangement for the demerger of Agrochemicals Division on a going concern basis into its WoS i.e., Natco Crop Health Sciences Limited. |
| 2026-02-12 | Quarterly Results & Interim Dividend | |
| 2025-11-14 | Quarterly Results & Interim Dividend |
About Natco Pharma
Natco Pharma Ltd. is leading pharmaceutical company in India, specializing in production of generic medicines, bulk drugs, & specialty pharmaceuticals. Founded in 1981, Natco has established itself as key player in global pharmaceutical industry, with strong focus on oncology, cardiology, & gastroenterology segments. company operates state of the art manufacturing facilities that comply with global regulatory standards, ensuring production of high quality medicines. Natco Pharma is known for its innovation, particularly in development of affordable generic versions of high cost drugs, which has made it preferred partner for healthcare providers worldwide.
NATCO Pharma Limited (NATCO) is pharmaceutical firm that focuses on research & development & is vertically integrated. Its core competencies include creating, producing, & selling complicated pharmaceuticals for specific therapeutic areas. NATCO is now present in three business categories of contract manufacturing business, active pharmaceutical ingredients (APIs), & final dosage formulations (FDF).
- NSE Symbol
- NATCOPHARM
- BSE Symbol
- 524816
- ISIN
- INE987B01026
Similar Stocks to Natco Pharma
Popular Stocks
Natco Pharma FAQs
Natco Pharma share price is ₹828 As on 06 September, 2026 | 00:57
The Market Cap of Natco Pharma is ₹14841.9 Cr As on 06 September, 2026 | 00:57
The P/E ratio of Natco Pharma is 13 As on 06 September, 2026 | 00:57
The PB ratio of Natco Pharma is 1.6 As on 06 September, 2026 | 00:57
The 52 week High & Low of Natco Pharma is ₹1226.8/₹789 respectively As on 06 September, 2026 | 00:57
Evaluate company's performance in pharmaceutical industry & its product pipeline before investing
Key metrics include revenue growth, product approvals, & profit margins.
Open Demat account with 5 Paisa Capital & post doing KYC & active account search for Natco Pharma share, you can then put order as you prefer.
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.